PDCD1 and cholangiocarcinoma: To improve the clinical efficacy of PD-1 inhibitors for advanced CCA, various combination therapies are being explored, such as PD-1 inhibitors combined with chemotherapy, targeted therapy, and local treatment (27, 28).